# US 2019/0170630 A1 · Rapid Measurement of Formed Blood Component Sedimentation Rate from Small Sample Volumes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0170630 A1
- Document ID: US20190170630A1
- Status: Published application
- Kind: A1
- Application number: 16/001,760
- Filed: 2018-06-06
- Published: 2019-06-06
- Earliest claimed: 2012-07-18
- Assignees: Theranos IP Company, LLC
- Applicants: Theranos IP Company, LLC
- Inventors: Mark Dayel; Samartha Anekal; Elizabeth A. Holmes
- Web page: https://patentgrep.com/patent/US20190170630A1

## CPC

- G01N 15/042: {by centrifuging and investigating centrifugates (centrifuges per se B04B)}
- G01N 15/05: in blood
- G01N 33/491: {by separating the blood components (G01N15/05 takes precedence)}
- G01N 2015/011: {with lysing, e.g. of erythrocytes}
- G01N 2015/012: {Red blood cells}
- G01N 2015/045: {by optical analysis}
- G01N 2015/055: {for hematocrite determination}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Devices and methods are described for measuring formed blood component sedimentation rate. Some of the methods may use (1) centrifugal techniques for separating red blood cells from plasma and (2) video and/or still imaging capability. Both may be used alone or in combination to accelerate formed blood component sedimentation and to measure its rate. In one example, the method may advantageously enable rapid measurement of sedimentation rate using small blood sample volumes. Automated image analysis can be used to determine both sedimentation rate and hematocrit. Automated techniques may be used to compensate for effects of hematocrit on uncorrected sedimentation rate data.

## Claims

### Claim at position 1

1-52. (canceled)

### Claim 53

A method comprising:
using an accelerated blood component separation technique using a first compaction force on a blood sample for a first period of time, wherein the accelerated blood component separation technique occurs at a first module of a benchtop, point-of-service system and wherein the blood sample is contained in a non-capillary vessel;
imaging the vessel to determine a position of formed component and plasma boundary in the vessel;
using the accelerated blood component separation technique on the blood sample for a second period of time at a second compaction force greater than the first compaction force associated with the first period of time;
determining a time-related compaction curve for at least one formed blood component in said blood sample after accelerated blood component separation based on the first position and the second position, said compaction curve having an initial approximately linear portion; and
determining sedimentation rate of the formed blood component in said accelerated blood component separation technique, based on at least the following: the linear portion of the compaction curve and a hematocrit correction factor based on a hematocrit of the sample.

### Claim 54 (depends on 53)

The method of claim 53 wherein the accelerated blood component separation technique comprises centrifuging the blood sample.

### Claim 55 (depends on 53)

The method of claim 53 comprises correcting for hematocrit effect on sedimentation rate by using the hematocrit correction factor based on the formula:
U
corr
=
U
uncorr
(
1
-
ϕ
ϕ
max
)
γ
,
where Uuncorr and Ucorr are the uncorrected (raw) and corrected sedimentation rates, φ is the volume fraction of cells (hematocrit), and φmax and γ are empirical parameters obtained by curve fitting.

### Claim 56 (depends on 55)

The method of claim 55 wherein curve fitting for the hematocrit correction factor comprises calibrating sedimentation rates from centrifuge based technique with sedimentation rates from a reference technique.

### Claim 57 (depends on 56)

The method of claim 56, wherein the reference technique is the Westergren technique.

### Claim 58 (depends on 53)

The method of claim 53, wherein said blood sample is about 100 uL or less.

### Claim 59 (depends on 53)

The method of claim 53, wherein said blood sample is about 50 uL or less.

### Claim 60 (depends on 54)

The method of claim 54, wherein formed component and plasma boundary comprise an erythrocyte/plasma interface boundary.

### Claim 61 (depends on 53)

The method of claim 53, wherein correcting for hematocrit comprises calculating a mathematical function for a plurality of formed blood component interface positions occurring in said curve, said function being operative to correct for sedimentation rate variations due to hematocrit.

### Claim 62 (depends on 54)

The method of claim 54, further comprising image transformation for conversion of a curved liquid interface to a flat interface.

### Claim 63 (depends on 54)

The method of claim 54, further comprising using a processor programmed to record interface position during a least a portion of centrifugation.

### Claim 64 (depends on 54)

The method of claim 54 wherein the non-capillary vessel comprises a centrifuge vessel.

### Claim 65 (depends on 53)

The method of claim 53 wherein the blood sample being processed has a volume in the vessel of about 20-25 μL.
